申请人:IMP INNOVATIONS LTD
公开号:WO2015159097A2
公开(公告)日:2015-10-22
The invention provides a method for identifying a subject with a disease or condition characterised by the presence of unwanted cells as being likely to respond to treatment comprising administration of a KDAC6 inhibitor having the structure of Formula (I), wherein said method comprises determining whether the subject's unwanted cells have or are likely to have an increased dependency on autophagy for survival, and wherein Formula (I) comprises: